Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pilot study switching protease inhibitor to etravirine in HIV-1-infected adults with viral suppression
2009-016455-21Phase 3Completed
- Sponsor
- Fight AIDS and Infectious Diseases Foundation
- Start
- Oct 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of etravirine in human immunodeficiency virus infection (HIV) (2 arms), sponsored by Fight AIDS and Infectious Diseases Foundation. Primary endpoint: Virologic efficacy at week 48. Started Oct 2009; status: completed.
02
Drugs
etravirine
03
Conditions
human immunodeficiency virus infection (HIV)
Beyond the preview
Go deeper on 2009-016455-21.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2009-016455-21.